Decheng Capital LLC Diversified Active

CIK: 0002010850 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $573,196 (100.0% shares, 0.0% debt)

Holdings (23)

CGON CG ONCOLOGY INC 44.8%
Value ($000) $256,651 Shares 6,371,669 Est. Cost $39.91 Unrealized -27.2%
NUVB Nuvation Bio Inc. 16.8%
Value ($000) $96,031 Shares 25,954,439 Est. Cost $3.05 Unrealized -10.7%
UPB Upstream Bio Inc. 10.8%
Value ($000) $61,796 Shares 3,285,293 Est. Cost $22.33 Unrealized -30.4%
AARD AARDVARK THERAPEUTICS INC 9.1%
Value ($000) $52,061 Shares 3,917,299 Est. Cost $11.23 Unrealized +0.4%
NAMS NEWAMSTERDAM PHARMA CO NV 3.3%
Value ($000) $18,687 Shares 657,051 Est. Cost $19.66 Unrealized +21.9%
MERUS NV 3.1%
Value ($000) $17,563 Shares 186,546 Est. Cost $51.07 Unrealized
RVMD REVOLUTION MEDICINES INC(NSM) 1.7%
Value ($000) $9,807 Shares 210,000 Est. Cost $50.40 Unrealized -22.3%
Lyell Immunopharma, Inc. 1.7%
Value ($000) $9,670 Shares 595,466 Est. Cost $0.64 Unrealized
BYSI BeyondSpring Inc. 1.4%
Value ($000) $7,758 Shares 4,286,104 Est. Cost $0.92 Unrealized +113.3%
ACRS Aclaris Therapeutics, Inc. 1.3%
Value ($000) $7,679 Shares 4,041,736 Est. Cost $2.33 Unrealized -25.2%
RCUS Arcus Biosciences, Inc 1.3%
Value ($000) $7,447 Shares 547,609 Est. Cost $12.03 Unrealized -13.6%
EQ Equillium Inc. 1.1%
Value ($000) $6,360 Shares 4,447,308 Est. Cost $0.59 Unrealized +77.9%
CRNX CRINETICS PHARMACEUTICALS IN 1.0%
Value ($000) $5,956 Shares 143,000 Est. Cost $39.97 Unrealized -20.0%
KRYS KRYSTAL BIOTECH INC 1.0%
Value ($000) $5,702 Shares 32,300 Est. Cost $122.01 Unrealized +22.7%
AURA Aura Biosciences, Inc. 0.6%
Value ($000) $3,186 Shares 515,555 Est. Cost $8.47 Unrealized -22.8%
ZNTL Zentalis Pharmaceuticals Inc. 0.3%
Value ($000) $1,998 Shares 1,323,327 Est. Cost $13.39 Unrealized -88.8%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.2%
Value ($000) $1,302 Shares 181,600 Est. Cost $50.17 Unrealized
FDMT 4D MOLECULAR THERAPEUTICS IN 0.1%
Value ($000) $806 Shares 92,748 Est. Cost $24.39 Unrealized -75.5%
ILMN Illumnia, Inc. 0.1%
Value ($000) $758 Shares 7,979 Est. Cost $122.34 Unrealized -18.9%
PYXS Pyxis Oncology, Inc (formerly Apexigen) 0.1%
Value ($000) $726 Shares 326,810 Est. Cost $1.71 Unrealized -15.9%
GRAL GRAIL INC 0.1%
Value ($000) $573 Shares 9,684 Est. Cost $16.22 Unrealized +135.6%
RZLT REZOLUTE INC 0.1%
Value ($000) $563 Shares 59,900 Est. Cost $3.71 Unrealized +79.3%
Nuvation Bio Inc. 0.0%
Value ($000) $115 Shares 646,057 Est. Cost $0.16 Unrealized